Pathological characteristics of lung tumors in Sri Lanka 2017-2021.
adenocarcinoma
demographics
epidemiology
lung neoplasms
pathology
Journal
Thoracic cancer
ISSN: 1759-7714
Titre abrégé: Thorac Cancer
Pays: Singapore
ID NLM: 101531441
Informations de publication
Date de publication:
07 Jan 2024
07 Jan 2024
Historique:
revised:
09
12
2023
received:
13
11
2023
accepted:
12
12
2023
medline:
8
1
2024
pubmed:
8
1
2024
entrez:
7
1
2024
Statut:
aheadofprint
Résumé
The prevalence of lung cancer is steadily increasing globally, and it is projected to become the second most prevalent cancer in men by 2030. Lung cancer is the leading cause of cancer-related deaths worldwide, accounting for approximately 3.61% of total fatalities. Despite its significant impact, many Asian countries, including Sri Lanka, lack precise data on the epidemiological patterns of lung tumors. This study pioneers a comprehensive exploration in Sri Lanka, delving into the demographic and clinicopathological characteristics of lung cancer patients. The study included 733 consecutive patients with lung tumors from 2017 to 2021, with a median age of 59 years. The most common site of tumors was the right lower lobe and left upper lobes. Adenocarcinoma was the most prevalent histopathological type of primary malignant lung tumors, while colorectal adenocarcinomas were the most common cause of metastatic deposits in the lungs. The most common benign tumor was hamartoma. Significantly, our findings unveiled associations between patient demographics and tumor types, underscoring the importance of factoring in age and gender in diagnostic assessments. Notably, the absence of a dedicated lung cancer screening program in Sri Lanka underscores the critical reliance on clinical suspicion and accurate diagnostic methods.
Identifiants
pubmed: 38185770
doi: 10.1111/1759-7714.15206
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Authors. Thoracic Cancer published by John Wiley & Sons Australia, Ltd.
Références
Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 2014;74(11):2913-2921.
Bade BC, Cruz CSD. Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med. 2020;41(1):1-24.
Metrics and Evaluation. GBD Compare. Seattle, WA: IHME; University of Washington; 2023.
Mathangasinghe Y et al. A descriptive analysis of lung and pleural tumours in a premier referral Centre in Sri Lanka. Sri Lanka J Surg. 2019;37(1):5-11.
Mathangasinghe Y, Pradeep S, Perera U, Punchihewa R. Pathological characteristics of mediastinal masses in Sri Lanka 2017-2021: a retrospective observational study. ERJ Open Res. 2022;8(4):256-2022.
Thoracic Tumours. WHO classification of Tumours. Lyon, France: International Agency for Research on Cancer; 2021.
Meza R, Meernik C, Jeon J, Cote ML. Lung cancer incidence trends by gender, race and histology in the United States, 1973-2010. PLoS ONE. 2015;10(3):e0121323.
Zhang C, Myers JL. Atlas of lung pathology. Springer; 2018. https://www.amazon.com/Atlas-Lung-Pathology-Anatomic-ebook/dp/B07FNGRH81#detailBullets_feature_div Accessed 5 Nov 2023.
Islami F, Torre LA, Jemal A. Global trends of lung cancer mortality and smoking prevalence. Transl Lung Cancer Res. 2015;4(4):327.
Katulanda P, Wickramasinghe K, Mahesh JG, Rathnapala A, Constantine GR, Sheriff R, et al. Prevalence and correlates of tobacco smoking in Sri Lanka. Asia Pacific J Public Health. 2011;23(6):861-869.